{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:12:35Z","timestamp":1792872755184,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jaut.2008.04.020","type":"journal-article","created":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T05:16:26Z","timestamp":1216876586000},"page":"123-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB\/W F1 mice"],"prefix":"10.1016","volume":"31","author":[{"given":"Christopher M.","family":"Reilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Robert","family":"Gogal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selen","family":"Olgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arben","family":"Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renna","family":"Sodhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen T.","family":"Samy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanford L.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Gilkeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilamadhab","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2008.04.020_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/bfgp\/2.3.234","article-title":"Global effects of histone modifications","volume":"2","author":"He","year":"2003","journal-title":"Brief Funct Genomic Proteomic"},{"key":"10.1016\/j.jaut.2008.04.020_bib2","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1124\/dmd.104.000638","article-title":"Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin A after intraperitoneal administration to mice","volume":"32","author":"Sanderson","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jaut.2008.04.020_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0145-2126(02)00222-9","article-title":"Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2\u2032-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells","volume":"27","author":"Shaker","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaut.2008.04.020_bib4","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2174\/0929867043365099","article-title":"Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view","volume":"11","author":"Vanhaecke","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jaut.2008.04.020_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0168-8278(03)00288-5","article-title":"Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes","volume":"39","author":"Papeleu","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaut.2008.04.020_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2008.04.020_bib7","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.0400380101","article-title":"Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect","volume":"101","author":"Reddy","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2008.04.020_bib8","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1073\/pnas.052702999","article-title":"The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines","volume":"99","author":"Leoni","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2008.04.020_bib9","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1073\/pnas.051507098","article-title":"Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells","volume":"98","author":"Mishra","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2008.04.020_bib10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2567.2007.02678.x","article-title":"Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment","volume":"122","author":"Bode","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2008.04.020_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/epi.1.2.2678","article-title":"Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosis","volume":"1","author":"Gray","year":"2006","journal-title":"Epigenetics"},{"key":"10.1016\/j.jaut.2008.04.020_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0961203307085248","article-title":"Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome","volume":"17","author":"Liu","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2008.04.020_bib13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/ar1504","article-title":"Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases","volume":"7","author":"Wahl","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaut.2008.04.020_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.0906-6705.2005.00301.x","article-title":"The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity","volume":"14","author":"Wenzel","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaut.2008.04.020_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/0891693031000068637","article-title":"A two-step hypothesis for the appearance of autoimmune disease","volume":"36","author":"Salaman","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2008.04.020_bib16","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.transproceed.2007.06.091","article-title":"Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation","volume":"39","author":"Pan","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaut.2008.04.020_bib17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay","volume":"170","author":"Ahmed","year":"1994","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaut.2008.04.020_bib18","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1172\/JCI117793","article-title":"Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB\/NZW mice by immunization with bacterial DNA","volume":"95","author":"Gilkeson","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2008.04.020_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7164\/antibiotics.49.453","article-title":"Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase","volume":"49","author":"Takahashi","year":"1996","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.jaut.2008.04.020_bib20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/138920107783018417","article-title":"Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cell","volume":"8","author":"Bruserud","year":"2007","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jaut.2008.04.020_bib21","first-page":"109","article-title":"Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells","volume":"21","author":"Takai","year":"2008","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jaut.2008.04.020_bib22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.bjp.0707166","article-title":"HDAC inhibitors as anti-inflammatory agents","volume":"150","author":"Adcock","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaut.2008.04.020_bib23","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1074\/jbc.M507213200","article-title":"Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation","volume":"281","author":"Takada","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaut.2008.04.020_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.20031519","article-title":"Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis","volume":"199","author":"Waters","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2008.04.020_bib25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/clim.2001.5079","article-title":"NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci","volume":"100","author":"Waters","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2008.04.020_bib26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2567.2005.02306.x","article-title":"Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus","volume":"117","author":"Lee","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2008.04.020_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2006.12.006","article-title":"Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis","volume":"123","author":"Sfikakis","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2008.04.020_bib28","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.4049\/jimmunol.175.12.8392","article-title":"Global natural regulatory T cell depletion in active systemic lupus erythematosus","volume":"175","author":"Miyara","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2008.04.020_bib29","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nm1652","article-title":"Deacetylase inhibition promotes the generation and function of regulatory T cells","volume":"13","author":"Tao","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2008.04.020_bib30","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/art.20976","article-title":"MRL\/Mp CD4+, CD25\u2212 T cells show reduced sensitivity to suppression by CD4+, CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus","volume":"52","author":"Monk","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2008.04.020_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1667\/RR1013.1","article-title":"Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr\/lpr mice with suppression of CD3+ CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells","volume":"169","author":"Tago","year":"2008","journal-title":"Radiat Res"},{"key":"10.1016\/j.jaut.2008.04.020_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI16153","article-title":"Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse","volume":"111","author":"Mishra","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2008.04.020_bib33","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.4049\/jimmunol.173.6.4171","article-title":"Modulation of renal disease in MRL\/lpr mice by suberoylanilide hydroxamic acid","volume":"173","author":"Reilly","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2008.04.020_bib34","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.4049\/jimmunol.173.12.7308","article-title":"A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes","volume":"173","author":"Gregg","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2008.04.020_bib35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1084\/jem.20042276","article-title":"TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells","volume":"201","author":"Marie","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2008.04.020_bib36","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.4049\/jimmunol.172.9.5149","article-title":"Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25\u2212 T cells through Foxp3 induction and down-regulation of Smad7","volume":"172","author":"Fantini","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2008.04.020_bib37","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2008.04.020_bib38","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4049\/jimmunol.172.2.834","article-title":"TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice","volume":"172","author":"Nakamura","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2008.04.020_bib39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1172\/JCI200420509","article-title":"Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3","volume":"114","author":"Ostroukhova","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2008.04.020_bib40","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.20858","article-title":"Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial","volume":"52","author":"Sfikakis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2008.04.020_bib41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0896-8411(03)00121-5","article-title":"Quantification of regulatory T cells in patients with systemic lupus erythematosus","volume":"21","author":"Crispin","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2008.04.020_bib42","first-page":"962","article-title":"Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase","volume":"7","author":"Butler","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaut.2008.04.020_bib43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/jpet.106.116202","article-title":"A metabolic screening study of trichostatin A (TSA) and TSA-like histone deacetylase inhibitors in rat and human primary hepatocyte cultures","volume":"321","author":"Elaut","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaut.2008.04.020_bib44","first-page":"245","article-title":"The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation","volume":"5","author":"Van Lint","year":"1996","journal-title":"Gene Expr"},{"key":"10.1016\/j.jaut.2008.04.020_bib45","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1084\/jem.188.5.985","article-title":"Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus","volume":"188","author":"Richards","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2008.04.020_bib46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1172\/JCI117373","article-title":"Interleukin 6 promotes murine lupus in NZB\/NZW F1 mice","volume":"94","author":"Finck","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2008.04.020_bib47","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/clin.1997.4390","article-title":"Cytokine mRNA expression in the B\/W mouse model of systemic lupus erythematosus\u2014analyses of strain, gender, and age effects","volume":"84","author":"McMurray","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaut.2008.04.020_bib48","doi-asserted-by":"crossref","first-page":"23851","DOI":"10.1074\/jbc.M300075200","article-title":"Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation","volume":"278","author":"Haller","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841108000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841108000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:59:04Z","timestamp":1760255944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841108000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0896841108000590"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2008.04.020","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB\/W F1 mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2008.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}